Coeptis Therapeutics (COEP) Stock Chart & Stock Price History $0.20 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Coeptis Therapeutics Stock Price Performance5 Day Performance-4.81%1 Month Performance+20.07%3 Month Performance-2.37%6 Month Performance-46.43%Year-To-Date Performance-74.74%1 Year Performance-79.94% Receive COEP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. COEP Stock Chart for Saturday, November, 2, 2024 COEP Chart by TradingView Coeptis Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$0.20$0.20-1.00%$0.22$0.19264,614 shs$7.87 million10/31/2024$0.21$0.20-4.26%$0.22$0.20158,724 shs$7.94 million10/30/2024$0.21$0.21+0.92%$0.22$0.2082,703 shs$7.75 million10/29/2024$0.21$0.21-0.48%$0.22$0.2033,225 shs$7.68 million10/28/2024$0.21$0.21+0.24%$0.23$0.2069,156 shs$7.72 million10/25/2024$0.21$0.21-1.66%$0.23$0.20238,566 shs$7.70 million Get the Latest News and Ratings for COEP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$0.23$0.21-6.64%$0.23$0.201.00 million shs$7.83 million10/23/2024$0.23$0.23-1.27%$0.24$0.22314,391 shs$8.39 million10/22/2024$0.22$0.23+3.11%$0.24$0.20893,314 shs$8.50 million10/21/2024$0.21$0.22+6.02%$0.23$0.20514,570 shs$8.24 million10/18/2024$0.20$0.21+5.23%$0.21$0.19337,676 shs$7.77 million10/17/2024$0.20$0.20+0.20%$0.20$0.19193,688 shs$7.39 million10/16/2024$0.20$0.20-1.19%$0.21$0.19353,417 shs$7.37 million10/15/2024$0.20$0.20-1.28%$0.21$0.20388,129 shs$7.46 million10/14/2024$0.18$0.20+13.74%$0.21$0.18659,086 shs$7.56 million10/11/2024$0.18$0.18+2.29%$0.18$0.18595,818 shs$6.64 million10/10/2024$0.18$0.18-1.52%$0.18$0.17377,360 shs$6.50 million10/09/2024$0.17$0.18+4.35%$0.19$0.17405,916 shs$6.60 million10/08/2024$0.17$0.17+0.47%$0.17$0.17391,267 shs$6.32 million10/07/2024$0.17$0.17-1.97%$0.17$0.17186,314 shs$6.29 million10/04/2024$0.17$0.17+4.79%$0.17$0.16578,159 shs$6.42 million10/03/2024$0.16$0.17+0.06%$0.18$0.16285,505 shs$6.13 million10/02/2024$0.17$0.16-1.26%$0.17$0.16280,166 shs$6.12 million10/01/2024$0.18$0.17-7.17%$0.18$0.1778,461 shs$6.20 million09/30/2024$0.17$0.18+5.70%$0.19$0.17762,946 shs$6.68 million09/27/2024$0.16$0.17+5.00%$0.18$0.15880,536 shs$6.32 million09/26/2024$0.17$0.16-3.11%$0.18$0.16287,036 shs$6.02 million09/25/2024$0.17$0.17-4.29%$0.17$0.17149,023 shs$6.21 million09/24/2024$0.18$0.17-1.80%$0.18$0.17175,918 shs$6.49 million09/23/2024$0.18$0.18-1.11%$0.18$0.1852,933 shs$6.61 million09/20/2024$0.19$0.18-2.76%$0.19$0.18141,698 shs$6.68 million09/19/2024$0.18$0.19+5.47%$0.19$0.18284,173 shs$6.87 million09/18/2024$0.18$0.18-2.50%$0.19$0.18117,774 shs$6.51 million09/17/2024$0.18$0.18-0.22%$0.19$0.1859,337 shs$6.68 million09/16/2024$0.19$0.18-4.14%$0.19$0.1869,933 shs$6.70 million09/13/2024$0.19$0.19-0.48%$0.19$0.1839,933 shs$7.48 million09/12/2024$0.18$0.19+2.27%$0.19$0.1819,436 shs$7.02 million09/11/2024$0.18$0.18+3.99%$0.19$0.1893,963 shs$6.86 million09/10/2024$0.19$0.18-5.27%$0.19$0.1896,541 shs$7.06 million09/09/2024$0.19$0.19+1.19%$0.20$0.18182,248 shs$7.46 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$0.19$0.19+0.27%$0.20$0.18206,257 shs$6.89 million09/05/2024$0.20$0.19-5.66%$0.20$0.18298,633 shs$6.87 million09/04/2024$0.20$0.20-1.36%$0.21$0.1927,107 shs$7.28 million09/03/2024$0.20$0.20-2.69%$0.21$0.20194,792 shs$7.38 million09/02/2024$0.20$0.20$0.21$0.20193,100 shs$7.58 million08/30/2024$0.20$0.20+2.30%$0.21$0.20193,161 shs$7.58 million08/29/2024$0.19$0.20+2.62%$0.20$0.19149,871 shs$7.41 million08/28/2024$0.20$0.19-3.14%$0.21$0.19126,572 shs$7.22 million08/27/2024$0.21$0.20-3.23%$0.22$0.20125,558 shs$7.46 million08/26/2024$0.21$0.21+1.27%$0.21$0.21180,829 shs$7.71 million08/23/2024$0.20$0.21+0.20%$0.21$0.20151,774 shs$7.61 million08/22/2024$0.21$0.20-3.49%$0.21$0.20112,620 shs$7.60 million08/21/2024$0.21$0.21-1.26%$0.22$0.21269,344 shs$7.87 million08/20/2024$0.21$0.21+1.13%$0.22$0.2094,889 shs$7.97 million08/19/2024$0.20$0.21+5.15%$0.22$0.20115,864 shs$7.88 million08/16/2024$0.21$0.20-2.75%$0.21$0.18389,374 shs$7.49 million08/15/2024$0.21$0.21-1.75%$0.21$0.2169,649 shs$7.71 million08/14/2024$0.21$0.21+3.07%$0.21$0.20164,669 shs$7.84 million08/13/2024$0.20$0.21+1.59%$0.21$0.20166,338 shs$7.61 million08/12/2024$0.20$0.20-0.10%$0.21$0.2029,515 shs$7.49 million08/09/2024$0.21$0.20-3.26%$0.21$0.20156,871 shs$7.50 million08/08/2024$0.20$0.21+2.15%$0.22$0.2065,011 shs$7.75 million08/07/2024$0.21$0.20-2.94%$0.21$0.20135,186 shs$7.59 million08/06/2024$0.19$0.21+11.13%$0.22$0.20175,974 shs$7.82 million08/05/2024$0.20$0.19-6.56%$0.20$0.17170,541 shs$7.53 million08/02/2024$0.20$0.20-0.88%$0.22$0.181.57 million shs$7.53 million08/01/2024$0.24$0.20-15.21%$0.23$0.19504,071 shs$7.60 million Related Companies Daré Bioscience Stock Price Chart Enlivex Therapeutics Stock Price Chart LianBio Stock Price Chart Natural Alternatives International Stock Price Chart Acurx Pharmaceuticals Stock Price Chart Lakeshore Biopharma Stock Price Chart Eyenovia Stock Price Chart MiNK Therapeutics Stock Price Chart ImmuCell Stock Price Chart Tempest Therapeutics Stock Price Chart Receive COEP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COEP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
